Article info

Original research
Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma

Authors

  • Zhuo Yu Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Yuyao Li Institute of Infectious Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Yue Li Institute of Infectious Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Jinghao Zhang Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Man Li Laboratory of Cellular Immunity, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Longshan Ji Laboratory of Cellular Immunity, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Yifei Tang Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Yanxi Zheng Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Jianguo Sheng Department of Ultrasound, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Qiucheng Han Department of Ultrasound, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Fu Li Department of Hepatopancreatobiliary Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Jianfeng Guo School of Pharmaceutical Sciences, Jilin University, Changchun, 130021, People’s Republic of China PubMed articlesGoogle scholar articles
  • Lingtai Wang Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Xuehua Sun Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of ChinaInstitute of Infectious Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Yueqiu Gao Department of Liver Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of ChinaInstitute of Infectious Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  • Hai Feng Institute of Infectious Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China PubMed articlesGoogle scholar articles
  1. Correspondence to Prof. Hai Feng; fogsea{at}163.com; Prof. Yueqiu Gao; gaoyueqiu{at}shutcm.edu.cn; Prof. Xuehua Sun; susan_sxh{at}shutcm.edu.cn
View Full Text

Citation

Yu Z, Li Y, Li Y, et al
Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma

Publication history

  • Accepted April 29, 2022
  • First published May 20, 2022.
Online issue publication 
May 20, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.